Similar articles

• Homocysteine and Alzheimer's disease.

  Leboeuf R. Leboeuf R. J Am Diet Assoc. 2003 Mar;103(3):304-7. doi: 10.1053/jada.2003.50083. J Am Diet Assoc. 2003. PMID: 12616250 Review. No abstract available.
• Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.

  Bleie Ø, Semb AG, Grundt H, Nordrehaug JE, Vollset SE, Ueland PM, Nilsen DW, Bakken AM, Refsum H, Nygård OK. Bleie Ø, et al. J Intern Med. 2007 Aug;262(2):244-53. doi: 10.1111/j.1365-2796.2007.01810.x. J Intern Med. 2007. PMID: 17645592 Clinical Trial.
• [Does diet affect our mood? The significance of folic acid and homocysteine].

  Karakuła H, Opolska A, Kowal A, Domański M, Płotka A, Perzyński J. Karakuła H, et al. Pol Merkur Lekarski. 2009 Feb;26(152):136-41. Pol Merkur Lekarski. 2009. PMID: 19388520 Review. Polish.
• Effect of fortified spread on homocysteine concentration in apparently healthy volunteers.

  van Vliet T, Jacobs RG, de Deckere E, van den Berg H, de Bree A, van der Put NM. van Vliet T, et al. Eur J Clin Nutr. 2007 Jun;61(6):769-78. doi: 10.1038/sj.ejcn.1602570. Epub 2006 Dec 6. Eur J Clin Nutr. 2007. PMID: 17151589 Clinical Trial.
• Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease.

  de Lau LM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. de Lau LM, et al. Neurology. 2006 Jul 25;67(2):315-8. doi: 10.1212/01.wnl.0000225050.57553.6d. Neurology. 2006. PMID: 16864826 Clinical Trial.